A retrospective evaluation of the combination of erenumab and onabotulinum toxin A for the prevention of chronic migraine

Arathi S Nandyala,Himanshu Suri,Carrie O Dougherty,Jessica Ailani

Clinical Neurology and Neurosurgery（2022）

引用 4|浏览3

暂无评分

摘要

•The combination of erenumab and Onabot A decreased the number of migraine days per month when compared to OnabotA alone.•Patients reported limited side effects while on the combination of erenumab and Onabot A.

查看译文

关键词

Chronic migraine,Erenumab,Onabotulinum toxin A

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要